Roche Wins Reversal Of $7M Accutane Verdict

Law360 (October 27, 2009, 5:30 PM EDT) -- Hoffmann-La Roche Inc. has won the reversal of a $7 million jury verdict in favor of a man who claimed he developed inflammatory bowel disease after taking the drugmaker's acne medication Accutane.

A Florida appeals court issued a per curiam order overturning the award on Tuesday, saying plaintiff Adam Mason had presented no evidence at his trial to support the claim that Accutane's deficient warning label was the proximate cause of his disease.

The Nutley, N.J.-based unit of Swiss pharmaceutical giant Roche Holding AG appealed the verdict to the Florida District Court of Appeal, First District, after a state trial court...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!